NEJM Study Demonstrates Safety and Efficacy of First Novel Monoclonal Antibody Specifically Developed to Treat Yellow Fever

… efficacy for TY014, a novel monoclonal antibody candidate treatment … Department of Infectious Diseases, Singapore General Hospital and co- … TY027, the first novel mAb that specifically targets … com KEYWORD: ASIA PACIFIC SINGAPORE INDUSTRY KEYWORD: HEALTH …